Call v. Zantac (Ranitidine) Products Liability Litigation
William Call |
Zantac (Ranitidine) Products Liability Litigation and GlaxoSmithKline |
9:2022cv81852 |
November 28, 2022 |
US District Court for the Southern District of Florida |
Robin L Rosenberg |
Other Statutory Actions |
28 U.S.C. ยง 1331 Federal Question |
None |
Docket Report
This docket was last retrieved on December 7, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 5 ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Case consolidated into MDL action. CLOSED for administrative purposes only. Signed by Judge Robin L. Rosenberg on 12/7/2022. See attached document for full details. (pes) |
Filing 4 Clerks Notice of Receipt of Filing Fee received on 11/28/2022 in the amount of $ 402.00, receipt number FLS261012. (asz) |
Filing 3 CLERK'S NOTICE of Docketing Amended Pretrial Order #24 Re: 20-md-2924. (pes) |
Filing 2 Judge Assignment to Judge Robin L. Rosenberg (pes) |
Filing 1 SHORT-FORM COMPLAINT against Zantac (Ranitidine) Products Liability Litigation, GlaxoSmithKline. Filing fees $ 402.00, filed by William Call. (Attachments: #1 Exhibit, #2 Letter)(pes) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.